Skip to main content
. 2023 Jun 14;12(6):1553–1578. doi: 10.1007/s40121-023-00822-0

Table 2.

Proportion of patients with HZ-related complications

Country Author and year N Mean age, years (SD) HZ-related complication, (%)
Any PHN Ophthalmic involvement Secondary bacterial infection Disseminated HZ Neurological
Singapore 10.2–85* 6.3–50* 6.4–14.9* 61.2* 31.3* 19.4*
Chen et al. (2015) [41] 347 66.5 (NR) 6.3
Mok and Tan (2013) [37] 421 53.6 (NR) 10.2a 16.4 6.4
Goh and Khoo (1997) [38] 164 48.8 (NR) 50
Oh et al. (1997) [40] 2262b 50.35 (21.71) 85 13.4 14.9 61.2 31.3 19.4
Thailand 21.2* 16.8–19.4* 7.2–8.4* 5* 8.4*
Chayangsu et al. (2016) [60] 118 57.6 (14.9) 21.2 8.4 5 8.4
Aunhachoke et al. (2011) [61] 180 58.9 (13.8) 19.4 7.2
Tunsuriyawong and Puavilai (2005) [59] 399 59 (7) 16.8
Sermswan et al. (2002) [43] 208 17.79
Philippines 12.22* 2.26* 4.98* 6.79*
Jara and Roa (2010) [79] 221 42.55 (2.75) 12.22 2.26 4.98 6.79

HZ herpes zoster, PHN postherpetic neuralgia, SD standard deviation

aClassified as early complications

bCohort consists of hospitalized patients, of which 67 had HZ

*Data represent the overall ranges in the proportion of patients within each category of complication per country. No data were reported from Indonesia, Malaysia, or Vietnam